CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions.

Autor: Herrera-Pariente C; Gastroenterology, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi I Sunyer (FRCB-IDIBAPS), CIBEREHD, Universitat de Barcelona, Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain., Bonjoch L; Gastroenterology, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi I Sunyer (FRCB-IDIBAPS), CIBEREHD, Universitat de Barcelona, Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain., Muñoz J; Gastroenterology, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi I Sunyer (FRCB-IDIBAPS), CIBEREHD, Universitat de Barcelona, Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain., Fernàndez G; Hospital Sant Joan de Déu, CIBERER, 08950, Barcelona, Spain., Soares de Lima Y; Gastroenterology, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi I Sunyer (FRCB-IDIBAPS), CIBEREHD, Universitat de Barcelona, Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain., Mahmood R; Gastroenterology, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi I Sunyer (FRCB-IDIBAPS), CIBEREHD, Universitat de Barcelona, Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain., Cuatrecasas M; Pathology, Hospital Clínic, FRCB-IDIBAPS, CIBEREHD, 08036, Barcelona, Spain., Ocaña T; Gastroenterology, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi I Sunyer (FRCB-IDIBAPS), CIBEREHD, Universitat de Barcelona, Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain., Lopez-Prades S; Pathology, Hospital Clínic, FRCB-IDIBAPS, CIBEREHD, 08036, Barcelona, Spain., Llargués-Sistac G; Gastroenterology, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi I Sunyer (FRCB-IDIBAPS), CIBEREHD, Universitat de Barcelona, Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain., Domínguez-Rovira X; Gastroenterology, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi I Sunyer (FRCB-IDIBAPS), CIBEREHD, Universitat de Barcelona, Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain., Llach J; Gastroenterology, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi I Sunyer (FRCB-IDIBAPS), CIBEREHD, Universitat de Barcelona, Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain., Luzko I; Gastroenterology, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi I Sunyer (FRCB-IDIBAPS), CIBEREHD, Universitat de Barcelona, Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain., Díaz-Gay M; Department of Cellular and Molecular Medicine and Department of Bioengineering and Moores Cancer Center, UC San Diego, La Jolla, San Diego, CA, 92093, USA., Lazaro C; Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, CIBERONC, 08908, Barcelona, Spain., Brunet J; Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, CIBERONC, 08908, Barcelona, Spain.; Hereditary Cancer Program, Catalan Institute of Oncology, IDIBGI, 17190, Girona, Spain., Castillo-Manzano C; Hereditary Cancer Program, Catalan Institute of Oncology, 08916, Badalona, Spain., García-González MA; Instituto de Investigación Sanitaria Aragón, Instituto Aragonés de Ciencias de La Salud, CIBEREHD, 50009, Zaragoza, Spain., Lanas A; Instituto de Investigación Sanitaria Aragón, Instituto Aragonés de Ciencias de La Salud, CIBEREHD, 50009, Zaragoza, Spain.; Gastroenterology, Hospital Clínico Universitario de Zaragoza, Instituto de Investigación Sanitaria Aragón, Universidad de Zaragoza, CIBEREHD, 50009, Zaragoza, Spain., Carrillo M; Gastroenterology, Centro de Investigación Biomédica de Canarias (CIBICAN), Hospital Universitario de Canarias, Instituto Universitario de Tecnologías Biomédicas (ITB), Universidad de La Laguna, 38320, Santa Cruz de Tenerife, Spain., Hernández San Gil R; Department of Medical Oncology, Hospital Universitario de Canarias, 38320, Tenerife, Spain., Quintero E; Gastroenterology, Centro de Investigación Biomédica de Canarias (CIBICAN), Hospital Universitario de Canarias, Instituto Universitario de Tecnologías Biomédicas (ITB), Universidad de La Laguna, 38320, Santa Cruz de Tenerife, Spain., Sala N; Unit of Nutrition and Cancer, Translational Research Laboratory, Catalan Institute of Oncology (ICO) and Bellvitge Biomedical Research Institute (IDIBELL), 08908, Barcelona, Spain., Llort G; Medical Oncology, Parc Taulí University Hospital, 08208, Sabadell, Spain., Aguilera L; Gastroenterology, Vall d'Hebron Research Institute, 08035, Barcelona, Spain., Carot L; Gastroenterology, Hospital del Mar, 08003, Barcelona, Spain., Diez-Redondo P; Hospital Universitario Río Hortega, 47012, Valladolid, Spain., Jover R; Gastroenterology, Departamento de Medicina Clínica, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria ISABIAL, Universidad Miguel Hernández, 03010, Alicante, Spain., Ramon Y Cajal T; Medical Oncology, Santa Creu I Sant Pau Hospital, 08041, Barcelona, Spain., Cubiella J; Gastroenterology, Complexo Hospitalario de Ourense, CIBEREHD, 32005, Ourense, Spain., Castells A; Gastroenterology, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi I Sunyer (FRCB-IDIBAPS), CIBEREHD, Universitat de Barcelona, Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain., Balaguer F; Gastroenterology, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi I Sunyer (FRCB-IDIBAPS), CIBEREHD, Universitat de Barcelona, Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain., Bujanda L; Department of Hepatology and Gastroenterology, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Biodonostia Health Research Institute - Donostia University Hospital, Universidad del País Vasco (UPV/EHU), 20014, San Sebastián, Spain., Castellví-Bel S; Gastroenterology, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi I Sunyer (FRCB-IDIBAPS), CIBEREHD, Universitat de Barcelona, Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain., Moreira L; Gastroenterology, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi I Sunyer (FRCB-IDIBAPS), CIBEREHD, Universitat de Barcelona, Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain. lmoreira@clinic.cat.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain. lmoreira@clinic.cat.

Publikováno v: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association [Gastric Cancer] 2024 Jul; Vol. 27 (4), pp. 747-759. Date of Electronic Publication: 2024 May 25.

Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers.

Autor: Lozano R; Genitourinary Cancer Translational Research Unit, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; Department of Medical Oncology, Hospital Universitario de Salamanca, Salamanca, Spain., Castro E; Genitourinary Cancer Translational Research Unit, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; Translational Cancer Genetics Group, Hospital Universitario 12 de Octubre, Madrid, Spain. Electronic address: ecastro.imas12@h12o.es., Lopez-Campos F; Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Thorne H; kConFab, The Peter MacCallum Cancer Centre, Melbourne, Australia., Ramirez-Backhaus M; Urology Department, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Aragon IM; Genitourinary Cancer Translational Research Unit, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain., Cendón-Florez Y; Genitourinary Cancer Translational Research Unit, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain., Gutierrez-Pecharroman A; Genitourinary Cancer Translational Research Unit, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; Department of Pathology, Hospital de Getafe, Getafe, Spain., Salles DC; Department of Pathology, John Hopkins University School of Medicine, Baltimore, USA., Romero-Laorden N; Medical Oncology Department, Hospital Universitario La Princesa, Madrid, Spain., Lorente D; Medical Oncology Department, Hospital Provincial de Castellón, Castellón de la Plana, Spain., González-Peramato P; Pathology Department, Hospital Universitario La Paz, Universidad Autónoma de Madrid, Madrid, Spain., Calatrava A; Pathology Department, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Alonso C; Genetics Department, Hospital Universitario La Princesa, Madrid, Spain., Anido U; Medical Oncology Department, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain., Arévalo-Lobera S; Medical Oncology Department, Hospital Universitario de Donostia, Donostia, Spain., Balmaña J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Vall d´HebronUniversity Hospital, Barcelona, Spain., Chirivella I; Medical Oncology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain., Juan-Fita MJ; Medical Oncology Department, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Llort G; Medical Oncology Department, Parc Taulí Hospital Universitari, Sabadell, Spain., Y Cajal TR; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Almagro E; Medical Oncology Department, Hospital Universitario Quirón, Pozuelo de Alarcón, Madrid, Spain., Alameda D; Genitourinary Cancer Translational Research Unit, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain., López-Casas PP; Genomics and Therapeutics in Prostate Cancer Group, Medical Oncology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria 12 de Octubre (Imas12), Madrid, Spain., Herrera B; Genitourinary Cancer Translational Research Unit, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; Urology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain., Mateo J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Vall d´HebronUniversity Hospital, Barcelona, Spain., Pritchard CC; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, USA., Antonarakis ES; Department of Medical Oncology, John Hopkins University School of Medicine, Baltimore, USA., Lotan TL; Department of Pathology, John Hopkins University School of Medicine, Baltimore, USA., Rubio-Briones J; Urology Department, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Sandhu S; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Olmos D; Genomics and Therapeutics in Prostate Cancer Group, Medical Oncology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria 12 de Octubre (Imas12), Madrid, Spain.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 May; Vol. 185, pp. 105-118. Date of Electronic Publication: 2023 Mar 05.

Kidney manifestations in patients with hereditary leiomyomatosis and renal cell cancer syndrome (LHRCC) in Spain

Autor: Sanchez A, Teule A, Lastra E, Balmana J, Robles L, Garcia J, Cajal T, Llort G, Fonfria M, Robledo M, Castillejo A, Duran M, Zuniga A, Gomez L, Garces E, Lopez A, Bosquet-Sanz M, Barbera V, Soto J

Publikováno v: ANNALS OF ONCOLOGY
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::418ecc9a17ef1f4624a9346ee33a5d47
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=9097

Association of premenopausal risk-reducing salpingo-oophorectomy with breast cancer risk in BRCA1/2 mutation carriers: Maximising bias-reduction

Autor: Stjepanovic, N, Villacampa, G, Nead, KT, Torres-Esquius, S, Melis, GG, Nathanson, KL, Teule, A, Brunet, J, Cajal, TRY, Llort, G, Dienstmann, R, Rue, M, Domchek, SM, Balmana, J

Publikováno v: EUROPEAN JOURNAL OF CANCER
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Background: Whether risk-reducing salpingo-oophorectomy (RRSO) in BRCA1/2 carriers reduces the breast cancer (BC) risk is conflicting, potentially due to methodological issues of prior analysis. We analysed the association between premenopausal RRSO

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::e6ca11c730d1ae4f791140e1bbeb3dde
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=13628

Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome.

Autor: Sánchez A; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Roos VH; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Navarro M; Hereditary Cancer Program, Oncobell Program, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Hospital Duran i Reynals., Pineda M; Hereditary Cancer Program, Oncobell Program, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Hospital Duran i Reynals., Caballol B; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Moreno L; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Carballal S; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Rodríguez-Alonso L; Department of Gastroenterology, Hospital Universitari de Bellvitge, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain., Ramon Y Cajal T; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Llort G; Department of Medical Oncology and Gastroenterology, Parc Tauli Hospital Universitari, Conscorci Sanitari de Terrasa, Sabadell-Terrasa, Spain., Piñol V; Department of Gastroenterology, University of Girona, Hospital Dr Josep Trueta, Girona, Spain., López-Fernández A; Department of Medical Oncology, Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Salces I; Department of Gastroenterology, Hospital 12 de Octubre, Madrid, Spain., Picó MD; Department of Gastroenterology, Hospital General Universitario de Elche, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Elche, Spain., Rivas L; Department of Gastroenterology, Complexo Hospitalario Universitario de Orense, Instituto de Investigación Sanitaria Galicia Sur, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Ourense, Spain., Bujanda L; Department of Gastroenterology, Biodonostia Health Research Institute, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), San Sebastián, Spain., Garzon M; Department of Gastroenterology, Hospital Virgen del Rocio, Sevilla, Spain., Pizarro A; Department of Gastroenterology, Hospital Virgen del Rocio, Sevilla, Spain., Martinez de Castro E; Department of Medical Oncology and Gastroenterology, Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Hospital Universitario Marqués de Valdecilla, Santander, Spain., López-Arias MJ; Department of Medical Oncology and Gastroenterology, Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Hospital Universitario Marqués de Valdecilla, Santander, Spain., Poves C; Department of Gastroenterology, Hospital Clínico San Carlos, Madrid, Spain., Garau C; Department of Gastroenterology, Hospital Universitario Son Llatzer, Palma de Mallorca, Spain., Rodriguez-Alcalde D; Department of Gastroenterology, Hospital de Móstoles, Móstoles, Spain., Herraiz M; Department of Gastroenterology, Clínica Universidad de Navarra, Pamplona, Spain., Alvarez-Urrutia C; Department of Gastroenterology, Institut Hospital del Mar d'Investigacions Biomèdiques (IMIM), Hospital del Mar Medical Research Institute, Barcelona Hospital del Mar, Barcelona; Spain., Dacal A; Department of Gastroenterology, Hospital Universitario Lucus Augusti, Lugo, Spain., Carrillo-Palau M; Department of Gastroenterology, Hospital Universitario de Canarias, Tenerife, Spain., Cid L; Department of Gastroenterology, Xerencia Xestion Integrada de Vigo, Servizo Galego de Saude (SERGAS), Research Group in Digestive Diseases, Instituto de Investigacion Sanitaria Galicia Sur (IISGS), SERGAS-Universidade de Vigo (UVIGO), Vigo, Spain., Ponce M; Department of Gastroenterology, Hospital Universitario de la Fe de Valencia, Valencia, Spain., Barreiro-Alonso E; Department of Gastroenterology, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain., Saperas E; Department of Gastroenterology, Hospital Universitari General de Catalunya, Sant Cugat, School of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain., Aguirre E; Genetic Counseling Unit, Department of Medical Oncology, Hospital Quirónsalud Zaragoza, Zaragoza, Spain., Romero C; Department of Medical Oncology and Gastroenterology, Parc Tauli Hospital Universitari, Conscorci Sanitari de Terrasa, Sabadell-Terrasa, Spain., Bastiaansen B; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Gonzalez-Acosta M; Hereditary Cancer Program, Oncobell Program, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Hospital Duran i Reynals., Morales-Romero B; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Ocaña T; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Rivero-Sánchez L; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Jung G; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Bessa X; Department of Gastroenterology, Institut Hospital del Mar d'Investigacions Biomèdiques (IMIM), Hospital del Mar Medical Research Institute, Barcelona Hospital del Mar, Barcelona; Spain., Cubiella J; Department of Gastroenterology, Complexo Hospitalario Universitario de Orense, Instituto de Investigación Sanitaria Galicia Sur, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Ourense, Spain., Jover R; Department of Gastroenterology, Hospital General Universitario de Alicante, Instituto de Investigación Biomédica ISABIAL, Alicante, Spain., Rodríguez-Moranta F; Department of Gastroenterology, Hospital Universitari de Bellvitge, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain., Balmaña J; Department of Medical Oncology, Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Brunet J; Hereditary Cancer Program, Catalan Institute of Oncology, Institut d'Investigacio Biomèdica de Giron Dr. Josep Trueta (IDIBGI), Medical Sciences Department, School of Medicine, University of Girona, Hospital Dr Josep Trueta, Girona, Spain., Castells A; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Dekker E; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Capella G; Hereditary Cancer Program, Oncobell Program, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Hospital Duran i Reynals., Serra-Burriel M; Center for Research in Health and Economics, Universitat Pompeu Fabra, Barcelona, Spain., Moreira L; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Pellise M; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Balaguer F; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain. Electronic address: fprunes@clinic.cat.

Publikováno v: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2022 Mar; Vol. 20 (3), pp. 611-621.e9. Date of Electronic Publication: 2020 Nov 03.